BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2830989)

  • 1. v-jun encodes a nuclear protein with enhancer binding properties of AP-1.
    Bos TJ; Bohmann D; Tsuchie H; Tjian R; Vogt PK
    Cell; 1988 Mar; 52(5):705-12. PubMed ID: 2830989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.
    Bohmann D; Bos TJ; Admon A; Nishimura T; Vogt PK; Tjian R
    Science; 1987 Dec; 238(4832):1386-92. PubMed ID: 2825349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
    Basso J; Briggs J; Findlay C; Bos T
    Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.
    Angel P; Allegretto EA; Okino ST; Hattori K; Boyle WJ; Hunter T; Karin M
    Nature; 1988 Mar; 332(6160):166-71. PubMed ID: 3347253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4.
    Harshman KD; Moye-Rowley WS; Parker CS
    Cell; 1988 Apr; 53(2):321-30. PubMed ID: 2834068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of three sequence-specific DNA-binding proteins which interact with the Rous sarcoma virus enhancer and upstream promoter elements.
    Goodwin GH
    J Virol; 1988 Jun; 62(6):2186-90. PubMed ID: 2835519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenicity of jun.
    Vogt PK; Bos TJ; Mitsunobu F; Nishimura T; Monteclaro FS; Su HY
    Princess Takamatsu Symp; 1989; 20():127-34. PubMed ID: 2562177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avian sarcoma virus 17 carries the jun oncogene.
    Maki Y; Bos TJ; Davis C; Starbuck M; Vogt PK
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2848-52. PubMed ID: 3033666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family.
    Kataoka K; Nishizawa M; Kawai S
    J Virol; 1993 Apr; 67(4):2133-41. PubMed ID: 8383235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen.
    Mitchell PJ; Wang C; Tjian R
    Cell; 1987 Sep; 50(6):847-61. PubMed ID: 3040262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes.
    Amemiya K; Traub R; Durham L; Major EO
    J Biol Chem; 1992 Jul; 267(20):14204-11. PubMed ID: 1321139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
    Kataoka K; Noda M; Nishizawa M
    Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer activity correlates with the oncogenic potential of avian retroviruses.
    Weber F; Schaffner W
    EMBO J; 1985 Apr; 4(4):949-56. PubMed ID: 2990916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor I interferes with transformation induced by nuclear oncogenes.
    Schuur ER; Kruse U; Iacovoni JS; Vogt PK
    Cell Growth Differ; 1995 Mar; 6(3):219-27. PubMed ID: 7794790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
    Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
    Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
    Bader AG; Schneider ML; Bister K; Hartl M
    Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor family.
    van Dam H; Offringa R; Meijer I; Stein B; Smits AM; Herrlich P; Bos JL; van der Eb AJ
    Mol Cell Biol; 1990 Nov; 10(11):5857-64. PubMed ID: 2172787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
    Kilbey A; Black EJ; Unlu M; Gillespie DA
    Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.
    Lee W; Mitchell P; Tjian R
    Cell; 1987 Jun; 49(6):741-52. PubMed ID: 3034433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor.
    Boulden A; Sealy L
    Virology; 1990 Jan; 174(1):204-16. PubMed ID: 2152992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.